Literature DB >> 11045675

Major histocompatibility complex class II expression by activated microglia caudal to lesions of descending tracts in the human spinal cord is not associated with a T cell response.

A B Schmitt1, A Buss, S Breuer, G A Brook, K Pech, D Martin, J Schoenen, J Noth, S Love, J M Schröder, G W Kreutzberg, W Nacimiento.   

Abstract

Lesion-induced microglial/macrophage responses were investigated in post-mortem human spinal cord tissue of 20 patients who had died at a range of survival times after spinal trauma or brain infarction. Caudal to the spinal cord injury or brain infarction, a strong increase in the number of activated microglial cells was observed within the denervated intermediate grey matter and ventral horn of patients who died shortly after the insult (4-14 days). These cells were positive for the leucocyte common antigen (LCA) and for the major histocompatibility complex class II antigen (MHC II), with only a small proportion staining for the CD68 antigen. After longer survival times (1-4 months), MHC II-immunoreactivity (MHC II-IR) was clearly reduced in the grey matter but abundant in the white matter, specifically within the degenerating corticospinal tract, co-localising with CD68. In this fibre tract, elevated MHC II-IR and CD68-IR were still detectable 1 year after trauma or stroke. It is likely that the subsequent expression of CD68 on MHC II-positive microglia reflects the conversion to a macrophage phenotype, when cells are phagocytosing degenerating presynaptic terminals in grey matter target regions at early survival times and removing axonal and myelin debris in descending tracts at later survival times. No T or B cell invasion or involvement of co-stimulatory B7 molecules (CD80 and CD86) was observed. It is possible that the up-regulation of MHC II on microglia that lack the expression of B7 molecules may be responsible for the prevention of a T cell response, thus protecting the spinal cord from secondary tissue damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045675     DOI: 10.1007/s004010000221

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  16 in total

Review 1.  Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

Authors:  D P Ankeny; P G Popovich
Journal:  Neuroscience       Date:  2008-07-04       Impact factor: 3.590

Review 2.  Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury.

Authors:  Alan I Faden; Junfang Wu; Bogdan A Stoica; David J Loane
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

3.  Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease.

Authors:  Donna M Wilcock; Jennifer Hurban; Alex M Helman; Tiffany L Sudduth; Katie L McCarty; Tina L Beckett; Joshua C Ferrell; M Paul Murphy; Erin L Abner; Frederick A Schmitt; Elizabeth Head
Journal:  Neurobiol Aging       Date:  2015-05-30       Impact factor: 4.673

Review 4.  Role of microglia in neurotrauma.

Authors:  David J Loane; Kimberly R Byrnes
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 5.  Targeting Translational Successes through CANSORT-SCI: Using Pet Dogs To Identify Effective Treatments for Spinal Cord Injury.

Authors:  Sarah A Moore; Nicolas Granger; Natasha J Olby; Ingo Spitzbarth; Nick D Jeffery; Andrea Tipold; Yvette S Nout-Lomas; Ronaldo C da Costa; Veronika M Stein; Linda J Noble-Haeusslein; Andrew R Blight; Robert G Grossman; D Michele Basso; Jonathan M Levine
Journal:  J Neurotrauma       Date:  2017-03-22       Impact factor: 5.269

6.  Cell cycle activation contributes to increased neuronal activity in the posterior thalamic nucleus and associated chronic hyperesthesia after rat spinal cord contusion.

Authors:  Junfang Wu; Charles Raver; Chunshu Piao; Asaf Keller; Alan I Faden
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

Review 7.  Mechanisms of chronic central neuropathic pain after spinal cord injury.

Authors:  Claire E Hulsebosch; Bryan C Hains; Eric D Crown; Susan M Carlton
Journal:  Brain Res Rev       Date:  2008-12-25

Review 8.  Stem cells in canine spinal cord injury--promise for regenerative therapy in a large animal model of human disease.

Authors:  Barbara G McMahill; Dori L Borjesson; Maya Sieber-Blum; Jan A Nolta; Beverly K Sturges
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

9.  IRF5 Signaling in Phagocytes Is Detrimental to Neonatal Hypoxic Ischemic Encephalopathy.

Authors:  Abdullah Al Mamun; Haifu Yu; Romana Sharmeen; Louise D McCullough; Fudong Liu
Journal:  Transl Stroke Res       Date:  2020-08-05       Impact factor: 6.800

10.  FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury.

Authors:  Zhiyuan Zhang; Zhiren Zhang; Uwe Fauser; Matthias Artelt; Michael Burnet; Hermann J Schluesener
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.